Our results provide novel insights on the role of CD28 and associated signaling mediators in IL-22 regulation in human CD4+ T cells and may provide the biological bases for the development of new therapeutic strategies to dampen inflammatory and autoimmune disorders. This evidence concerns the gene IL22 and autoimmune disease.